More than 16 countries are participating in a project in which 50 patients in Israel are being treated with a new drug to combat Alzheimer’s disease, according to the Israeli daily Ha’aretz. The patients will be treated with the drug, AIT-0-82, for six months, with the option of continuing treatment for an additional year, the paper reported.
Keep Jewish Stories in Focus.
JTA has documented Jewish history in real-time for over a century. Keep our journalism strong by joining us in supporting independent, award-winning reporting.
The Archive of the Jewish Telegraphic Agency includes articles published from 1923 to 2008. Archive stories reflect the journalistic standards and practices of the time they were published.
